Squarepoint Ops LLC Assembly Biosciences, Inc. Transaction History

Squarepoint Ops LLC

$59.6 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.09 - $20.4 $11,428 - $213,893	10,485 New	10,485 $13,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.45 $19,474 - $32,680	-13,339 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.13 - $3.46 $28,412 - $46,152	13,339 New	13,339 $31,000
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $131,480 - $157,776	-34,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $41,849 - $64,078	-9,665 Reduced 21.83%	34,600 $159,000
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $129,503 - $459,775	26,592 Added 150.47%	44,265 $268,000
Q3 2020 Nov 16, 2020	BUY	$15.08 - $27.04 $71,494 - $128,196	4,741 Added 36.66%	17,673 $291,000
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $188,419 - $309,850	12,932 New	12,932 $302,000
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $440,839 - $911,297	-42,925 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.36 - $23.81 $133,216 - $379,412	-15,935 Reduced 27.07%	42,925 $878,000
Q3 2019 Nov 14, 2019	BUY	$9.83 - $14.82 $410,461 - $618,823	41,756 Added 244.13%	58,860 $579,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $220,641 - $355,763	17,104 New	17,104 $231,000
Q1 2019 May 15, 2019	SELL	$17.7 - $24.93 $464,306 - $653,963	-26,232 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$19.05 - $36.45 $348,900 - $667,581	18,315 Added 231.34%	26,232 $593,000
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $93,698 - $120,438	2,723 Added 52.43%	7,917 $294,000
Q2 2018 Aug 14, 2018	BUY	$39.21 - $50.29 $203,656 - $261,206	5,194 New	5,194 $204,000
Q1 2018 May 15, 2018	SELL	$41.7 - $64.16 $346,110 - $532,528	-8,300 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $237,214 - $414,253	8,300	8,300 $376,000

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$277,028
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account